<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; Gleevec</title>
	<atom:link href="http://oralcancernews.org/wp/tag/gleevec/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Thu, 09 Sep 2010 19:35:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Collaboration In The Quest To Contain Cancer</title>
		<link>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/</link>
		<comments>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/#comments</comments>
		<pubDate>Thu, 15 Oct 2009 19:44:10 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[chronic myelogenous leukemia]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Gleevec]]></category>
		<category><![CDATA[Imatinib]]></category>
		<category><![CDATA[infections]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6971</guid>
		<description><![CDATA[
			
				
			
		
Source: forbes.com
Author: Thomas Stossel
This year&#8217;s Lasker Foundation annual prize for medical breakthroughs&#8211;the American version of the Nobel Prize&#8211;recognizes a breakthrough cancer treatment that has revolutionized chemotherapy, a &#8220;targeted therapy for chronic myelogenous leukemia.&#8221; But more symbolic&#8211;and no doubt controversial&#8211;was to whom the prize was awarded: two academic scientists and a former drug company employee.
Ironically, the [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/collaboration-in-the-quest-to-contain-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Screening could lead to more potent cancer drugs</title>
		<link>http://oralcancernews.org/wp/screening-could-lead-to-more-potent-cancer-drugs/</link>
		<comments>http://oralcancernews.org/wp/screening-could-lead-to-more-potent-cancer-drugs/#comments</comments>
		<pubDate>Fri, 14 Aug 2009 18:27:04 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[antibodies]]></category>
		<category><![CDATA[cancer stem cells]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[genetic manipulation]]></category>
		<category><![CDATA[Gleevec]]></category>
		<category><![CDATA[leukemia]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=6416</guid>
		<description><![CDATA[
			
				
			
		
Source: nytimes.com
Author: Nicholas Wade
Researchers have discovered a way to identify drugs that can specifically attack and kill cancer stem cells, a finding that could lead to a new generation of anticancer medicines and a new strategy of treatment.
Many researchers believe that tumor growth is driven by cancerous stem cells that, for reasons not understood, are [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/screening-could-lead-to-more-potent-cancer-drugs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vitamin C may interfere with cancer treatment</title>
		<link>http://oralcancernews.org/wp/vitamin-c-may-interfere-with-cancer-treatment/</link>
		<comments>http://oralcancernews.org/wp/vitamin-c-may-interfere-with-cancer-treatment/#comments</comments>
		<pubDate>Wed, 01 Oct 2008 14:50:57 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gleevec]]></category>
		<category><![CDATA[Sloan-Kettering]]></category>
		<category><![CDATA[supplements]]></category>
		<category><![CDATA[vitamin C]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=482</guid>
		<description><![CDATA[
			
				
			
		
Source: New York Times (nytimes.com)
Author: Tara Parker-Pope
Many people gobble big doses of vitamin C in hopes of boosting their immune system and warding off illness. But new research shows that in people with cancer, the vitamin may do more harm than good.
Researchers at Memorial Sloan-Kettering Cancer Center in New York studied the effects of vitamin [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/vitamin-c-may-interfere-with-cancer-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
